Hasil Pencarian  ::  Simpan CSV :: Kembali

"Penelitian longitudinal prospektif analitik untuk menilai ketepatan prediksi timbulnya penyakit trofoblas ganas melalui sistem penilaian prognosis mola hidatidosa yang dikembangkan oleh NETDC (New England Trophoblast Disease Center) telah dilakukan. Di antara parameter faktor risiko yang dinilai; usia penderita, jenis mola hidatidosa, pembesaran uterus, kadar hCG serum, kista lutein, serta ada-tidaknya komplikasi merupakan factor risiko yang bermakna untuk timbulnya keganasan setelah mola hidatidosa dievakuasi (p=0,032). Penelitian dilakukan pada 50 penderita mola hidatidosa dengan pengamatan lanjutan selama 1 tahun (Januari 2001-Desember 2002) di Bagian Obstetri dan Ginekologi RS Mohammad Hoesin, Palembang. Hasilnya menunjukan prediksi keganasan skor NETDC 50% pada risiko tinggi dan 10% risiko rendah untuk berkembang menjadi ganas (p<0,05). Hasil ini lebih besar dibandingkan dengan nilai yang diajukan WHO yaitu 19-30%. Risiko untuk terjadinya keganasan pasca mola hidatidosa pada kelompok risiko tinggi ialah 9,0 kali lebih tinggi disbanding pada kelompok risiko rendah (CI: 1,769-45,786). (Med J Indones 2004; 13: 40-6)

---

A prospective longitudinal analytic study assessing the efficacy of NETDC (New England Trophoblastic Disease Center) prognostic index score in predicting malignancy after hydatidiform mole had been performed. Of the parameter evaluated; age of patients, type of hydatidiform mole, uterine enlargement, serum hCG level, lutein cyst, and presence of complicating factors were significant risk factors for malignancy after hydatidiform mole were evacuated (p<0.032). The study were done on 50 women diagnosed with hydatidiform mole with 1 year observation (January 2001-December 2002) at the Department of Obstetrics and Gynecology, Mohammad Hoesin Hospital, Palembang. The results showed that the NETDC prognostic index score predicted malignancy in 50% of high risk group and 10% in low risk group (p<0.05). This showed a higher number than that found by the WHO (19%-30%). The risk for incidence of malignancy after hydatidiform mole in the high risk group is 9.0 times higher compared to that of the low risk group (CI: 1.769-45.786). (Med J Indones 2004; 13: 40-6)"

"Molahidatidosa merupakan kehamilan yang abnormal yang pada pemeriksaan histopatologi ditandai dengan proliferasi sel sitotrofoblas, sinsitiotrofoblas, dan intermediate trofoblas. Vitamin A mengontrol proliferasi sel, dan penurunan kadar vitamin A menyebabkan proliferasi tidak terkontrol. Sampai saat ini, belum diketahui apakah terdapat hubungan antara defisiensi vitamin A dengan molahidatidosa. Penelitian ini bertujuan untuk membuktikan keberadaan reseptor retinol binding protein (RBP) pada sel trofoblas molahidatidosa, sehingga dapat menjelaskan hubungan vitamin A dengan molahidatidosa. Penelitian ini adalah penelitian deskriftif. Spesimen penelitian adalah blok parafin molahidatidosa tahun 2005. Pemeriksaan dilakukan dengan teknik imunohistokimia tidak langsung. Dilakukan pemeriksaan sebaran sel yang berekspresi, kekuatan ekspresi dan letak ekspresi reseptor RBP. Terdapat 21 spesimen dengan sebaran ekspresi reseptor RBP pada sel trofoblas molahidatidosa antara sedang sampai padat. Ekspresi reseptor RBP pada sel sinsitiotrofoblas lebih kuat jika dibandingkan dengan sel sitotrofoblas. Ekspresi reseptor RBP dijumpai pada membran sel dan sitoplasma.

---

Hydatidiform mole is an abnormal pregnancy characterized by the proliferation of cytotrophoblastic, syncytiotrophoblastic, and intermediate trophoblastic cells in histological specimens. Vitamin A plays a role in controlling cell proliferation, and decrease in vitamin A level will cause an uncontrollable proliferation. To date, it is not known whether there is a relationship between vitamin A deficiency and hydatidiform mole. This study aimed to demonstrate the presence of retinol binding protein (RBP) receptors in the hydatidiform mole trophoblastic cells, that would provide explanation on the relationship of vitamin A and hydatidiform mole. The study was a descriptive study. The specimens of the study were paraffin blocks of hydatidiform mole made in 2005, and the examinations were performed by indirect immunohistochemistry. We examined the distribution of the cells showing expression of RBP receptor, the strength of expression, and location of the expression. As many as 21 specimens were collected, and the distributions of RBP receptor expression in hydatidiform mole trophoblastic cells ranged from moderate to dense. The expression in syncytiotrophoblastic cells was stronger than that in cytotrophoblastic cells. Furthermore, the expressions were found in the cell membranes and cytoplasm."

"In this volume Dr Hui has brought together a comprehensive overview of gestational trophoblastic disease that includes all the currently recognized entities: complete and partial hydatidiform moles, placental site trophoblastic tumor, epithelioid trophoblastic tumor, gestational choriocarcinoma, persistent gestational trophoblastic neoplasia, placental site nodule and exaggerated placental site reaction. Each entity is reviewed in detail, with emphasis on genetic background, clinical presentation, pathologic findings and ancillary studies, differential diagnosis and clinicopathological correlations.Descriptions of the pathology are supported by numerous excellent photomicrographs. Recent advances in our understanding of the genetics of gestational trophoblastic diseases are stressed. Introductory chapters cover the developmental biology of the placenta and the genetic basis of gestational trophoblastic disease, and one chapter is devoted to the molecular diagnosis of gestational trophoblastic disease. This chapter includes a review of the use of short tandem repeat (STR) genotyping which is of particular value in the diagnosis of hydatidiform moles. The final chapter covers clinical aspects of gestational trophoblastic disease, including treatment. The text throughout is current and thoroughly referenced. "

"Latar Belakang : Palliative prognostic index (PPI) adalah skor prognostik yang umum digunakan di unit perawatan paliatif. PPI mencakup lima variabel klinis yang didasari oleh penelitian Morita dkk pada tahun 1999, untuk menilai kesintasan kurang dari 3 minggu, 3 - 6 minggu atau lebih dari 6 minggu. Penelitian ini bertujuan untuk melakukan validasi skor PPI pada pasien kanker stadium lanjut yang dikonsulkan ke tim paliatif di RSCM.Tujuan : Menilai performa model skor PPI dalam memprediksi kesintasan pasien stadium lanjut di RSCM.Metode : Penelitian ini merupakan studi kohort retrospektif yang dilakukan di rumah sakit tersier terhadap pasien kanker stadium lanjut yang dikonsulkan ke tim paliatif pada Juli 2017 sampai Desember 2018S. Performa kalibrasi skor PPI dinilai dengan uji Hosmer-Lemeshow dan plot kalibrasi. Untuk menilai akurasi prediktif skor PPI, sensitivitas, spesifisitas, PPV, NPV dan akurasi setiap grup skor PPI dihitung. Diskriminasi dinilai dengan area under the reciever operating characteristic curve (AUC).Hasil Penelitian : Sebanyak 160 pasien dengan rentang usia 20–83 tahun masuk dalam penelitian ini. Performa kalibrasi skor PPI berdasarkan uji Hosmer menunjukan nilai P=0,259. Akurasi skor PPI dalam memprediksi kesintasan pasien kanker stadium lanjut penelitian untuk kesintasan < 3 minggu 81% , dengan sensitivitas 85%, spesifisitas 70%, PPV 86%, dan NPV 67%. Akurasi untuk prediksi kesintasan 3-6 minggu 76%, sensitivitas 66%, spesifisitas 88%, PPV 85% dan NPV 70%. Performa diskriminasi skor PPI ditunjukkan dengan nilai AUC sebesar 0,822 (IK95% 0,749-0,895).Simpulan : Skor Palliative Prognostic Index memiliki performa akurasi dan diskriminasi yang baik dalam memprediksi kesintasan pasien kanker stadium lanjut dalam perawatan paliatif di RSCM.

---

Background : Palliative prognostic index (PPI) is a prognostic score that is commonly used in palliative care units. PPI includes five clinical variables based on the study of Morita et al in 1999, to assess survival in less than 3 weeks, 3-6 weeks or more than 6 weeks. This study aims to validate PPI scores in advanced cancer patients who are consulted to the palliative team at our hospital.

Objective : To assess the performance of the PPI score model in predicting survival in advanced cancerpatients at Cipto Mangunkusumo General Hospital.

Methods : This research is a retrospective cohort study conducted in a tertiary hospital of advanced cancer patients who were consulted to the palliative team from July 2017 to December 2018S. PPI score calibration performance was assessed with the Hosmer-Lemeshow test and calibration plot. To assess the predictive accuracy of PPI scores, sensitivity, specificity, PPV, NPV and accuracy of each PPI score group are calculated. Discrimination is assessed with area under the reciever operating characteristic curve (AUC).

Results : Total of 160 patients with an age range of 20-83 years participated in this study. PPI score calibration performance based on the Hosmer Lemeshow test in patients with advanced cancer showed a P value of 0.259. The accuracy of PPI scores in predicting survival in advanced cancer patients in studies for survival <3 weeks 81%, with a sensitivity of 85%, specificity 70%, PPV 86%, and NPV 67%. Accuracy for prediction of survival 3-6 weeks 76%, sensitivity 66%, specificity 88%, PPV 85% and NPV 70%. PPI score discrimination performance is shown with AUC value of 0.822 (IK95% 0.749-0.895).

Conclusion : Palliative Prognostic Index scores have good accuracy and discrimination in predicting the survival of advanced cancer patients in palliative care at RSCM."

"ABSTRAKLatar Belakang Peningkatan insidensi tumor metastasis intrakranial setiap tahunnya, juga diikuti oleh meningkatnya angka disabilitas dan mortalitas pada pasien. Terapi standar pada tumor metastasis otak adalah WBRT, SRS, operasi atau kombinasi dari ketiganya. Dengan semua pilihan terapi yang ada, sangat penting untuk memerhatikan prognosis pasien dengan tumor metastasis otak untuk menentukan jenis terapi yang sesuai, salah satunya dengan menggunakan indeks prognosis. Belum terdapat data yang menggambarkan profil demografis dan kesintasan pasien tumor metastasis otak di Indonesia dengan menerapkan indeks prognosis yang sudah ada.Tujuan dan Metode Penelitian ini merupakan studi cohort retrospektif untuk melihat kesesuaian hasil analisis kesintasan pasien tumor metastasis otak di Departemen Radioterapi RSUPN Dr. Cipto Mangunkusumo tahun 2012-2014 dengan data acuan indeks RPA, GPA, dan BSBM.Hasil Terdapat 62 subyek yang diikutsertakan dalam penelitian ini setelah mendapat persetujuan. Median kesintasan keseluruhan mencapai 9,16 bulan. Hasil analisis kesintasan berdasarkan indeks RPA memperlihatkan median kesintasan Kelas I, Kelas II dan Kelas III, secara berurutan 16.3 bulan, 11.2 bulan, dan 4.7 bulan. Karakteristik dan median kesintasan subyek pengamatan berdasarkan indeks GPA, secara berurutan mulai dari GPA 0-1 sampai GPA 3,5-4 adalah 4.3, 10.4, 12.4, dan 16.3 bulan. Hasil penerapan kedua indeks tersebut terlihat sesuai dengan data acuan penelitian pendahulunya. Namun indeks BSBM tidak mampu memperlihatkan hasil yang sesuai saat diterapkan pada populasi sampel penelitian.Kesimpulan Indeks RPA dan GPA dapat digunakan untuk memprediksi prognosis pasien tumor metastasis otak di RSUPN-CM karena memberikan karakterisitik yang sesuai dengan data acuan. Indeks GPA dianggap lebih baik karena menggunakan variabel yang lebih objektif.

---

ABSTRACTBackground The incidence of intracranial metastasis has increased annually, which also followed by the increased number of patient rsquo s disability and mortality. Standard therapy in brain metastasis are Whole Brain Radiotherapy WBRT , Stereotactic Radio Surgery SRS , surgery, or combination of all. With all these treatment options available, it is very important to consider the prognosis in order to decide which therapy is appropriate. One of the methods that can be used to determine the prognosis is by using the prognostic indices. Currently, there has been no data or report about the demographic and survival profile of patients with brain metastastis in Indonesia using the available index prognosis.Methods This is a retrospective cohort study to evaluate the survival analysis in patients with brain metastasis that are undergoing treatment in Radiotherapy Department, RSUPN Dr. Cipto Mangunkusumo in 2012 2014 based on RPA, GPA, and BSBM index.Results Sixty two patients are included in this study after obtaining the approved consent. The median of survival rate is 9.16 months. Survival analysis based on RPA index showed median class I, II, and III are 16.3, 11.2, and 4.7 months, respectively. Characteristics and median observer based on GPA, from GPA 0 1 to GPA 3.5 4 are 4.3, 10.4, 12.4, and 16.3 months, respectively. These findings are similar with the previous studies. However, BSBM index does not able to illustrate the result that is appropriate when it is being applied to the subjects of this study.Conclusions RPA and GPA index can be used to predict the prognosis in patients with brain metastasis that are undergoing treatment in RSUPN Dr. Cipto Mangunkusumo because it provides characteristics, which correspond to the reference data. GPA index is considered better because it uses more objective variables."

"Penelitian ini membahas perbandingan performa diagnostik sistem skoring International Ovarian Tumor Analysis (IOTA) dengan Risk of Malignancy Index-4 (RMI-4) dan indeks morfologi Sassone dalam memprediksi keganasan ovarium prabedah. Dilakukan uji diagnostik potong-lintang secara retrospektif dengan pasien neoplasma ovarium di RSUPN Dr. Cipto Mangunkusumo dari Januari hingga Desember 2013. Nilai diagnostik dari keempat metode skoring dihitung dengan luaran: sensitivitas, spesifisitas, nilai prediksi positif, nilai prediksi negatif, akurasi dan nilai AUC. Penelitian ini menyimpulkan IOTA simple-rules memiliki performa diagnostik lebih baik dibandingkan IOTA subgroup, RMI-4 dan indeks morfologi Sassone.

---

This study compared diagnostic performance of scoring system of International Ovarian Tumor Analysis (IOTA) with Risk of Malignancy Index-4 (RMI-4) and Sassone morphology index to predict ovarian malignancy preoperatively. A retrospective study was done involving subject with ovarian neoplasm at National General Hospital Dr. Cipto Mangunkusumo on January to December 2013. Sensitivity, specificity, positive predictive value, negative predictive value, accuracy and AUC value were calculated. This study concluded that diagnostic performance of IOTA simple-rules were significantly better than IOTA subgroup, RMI-4 and Sassone morphology index."

"ABSTRAKTujuan: Meninjau status faktor-faktor prognostik tumor ginjal. Metode: Jenis penelitian ini adalah studi deskriptif analitik pada seluruh pasien tumor ginjal yang berobat ke RSUP H. Adam Malik tahun 2011 hingga 2015. Hasil: Jumlah sampel pada penelitian ini adalah 38 pasien. Dijumpai tujuh pasien hidup. Dari hasil uji multivariat, tindakan nefrektomi merupakan satu-satunya faktor prognostik pada pasien tumor ginjal. Tingkat mortalitas 0.056x lebih rendah pada pasien yang dilakukan nefrektomi dibanding pasien yang tidak dilakukan nefrektomi. Kesimpulan: Tindakan nefrektomi masih memiliki tempat dalam penanganan tumor ginjal, bahkan pada pasien yang berobat dengan stadium lanjut.

---

ABSTRACTObjective To review the status of prognostic factors in kidney cancer. Methods This is an analytic descriptive study of all kidney cancer patients treated at Haji Adam Malik Hospital between 2011 and 2015. Results The number of samples analyzed in this study were 38 patients. We found seven patients remain alive. From the results of multivariate analysis, nephrectomy is the only prognostic factor in patients with kidney cancer. Mortality rate was 0.056x lower in patients who underwent nephrectomy compared with patients who did not underwent nephrectomy. Conclusion Nephrectomy still has a place in kidney cancer management, even in patients with advanced stage. "

"ABSTRAKLatar Belakang : Komplikasi paru pasca operasi memiliki kontribusi penting dalam peningkatan angka morbiditas, mortalitas, dan lamanya perawatan. Terdapat beberapa faktor risiko diantaranya: status kesehatan pasien, jenis operasi, dan jenis anestesi yang digunakan. Model skor indeks risiko yang dikembangkan Arozullah dapat digunakan untuk memprediksi komplikasi gagal napas dan pneumonia pasca operasi. Oleh karena terdapat perbedaan karakteristik populasi pasien, maka perlu dilakukan validasi untuk mengetahui performa model skor tersebut. Tujuan : Menilai performa kalibrasi dan diskriminasi model skor indeks risiko komplikasi paru Arozullah dalam memprediksi komplikasi gagal napas dan pneumonia pasca operasi pada pasien yang menjalani operasi non kardiak di Rumah Sakit Umum Pusat Nasional Cipto Mangunkusumo (RSCM). Metode :Penelitian ini merupakan studi kohort retrospektif pada populasi pasien yang menjalani operasi nonkardiak di RSCM dari bulan Januari sampai Desember 2015. Variabel yang dinilai adalah jenis operasi, usia, operasi darurat, riwayat Penyakit Paru Obstruksi Kronis (PPOK), albumin darah, ureum darah, status fungsional, penurunan berat badan, perokok, penggunaan alkohol, transfusi darah pre operasi, anestesi umum, riwayat cerebrovascular disease, gangguan sensorium akut, penggunaan steroid kronis. Luaran yang dinilai adalah komplikasi gagal napas dan pneumonia 30 hari pasca operasi. Performa kalibrasi dinilai dengan uji Hosmer-Lemeshow. Performa diskriminasi dinilai dengan area under the curve (AUC). Hasil : Didapatkan 403 subyek memenuhi kriteria penerimaan dengan 74 subyek mengalami kejadian komplikasi paru (18,4%). Terdapat 52 subyek mengalami gagal napas dan 34 subyek komplikasi pneumonia, serta terdapat 12 subyek mengalami komplikasi keduanya. Uji Hosmer-Lemeshow pada komplikasi gagal napas menunjukkan p=0,333, sedangkan nilai AUC 0,911. Pada komplikasi pneumonia didapatkan hasil kalibrasi dengan nilai p=0,617 dan nilai diskriminasi AUC 0,789. Simpulan : Model skor perioperatif paru Arozullah mempunyai performa yang baik dalam memprediksi komplikasi gagal napas dan pneumonia 30 hari pasca operasi pasien di RSCM Kata Kunci : Gagal napas, pneumonia, operasi non kardiak, validasi, indeks risiko Arozullah.

---

ABSTRACTRisk Index Score Perioperative Arozullah of Surgical Patients in Cipto Mangunkusumo General Hospital 2015 Background: Post operative pulmonary complication had important effect in increasing morbidity, mortality as well as length of stay. Several factor contributing those such as patient?s health status, type of operation and type anaesthesia used. There were risk score develop by Arozullah that can be used to predict the possibility of respiratory failure and post operative pneumonia. Due to the differences of the characteristic population, the study needed internal validation to discover the performance of the Arozullah score. Objectives: To assess the performance of calibration and discrimination of Arozullah?s model risk score in predicting complications of respiratory failure and pneumonia postoperative in patients under going non-cardiac surgery in Cipto Mangunkusumo General Hospital (RSCM) Methods: A cohort retrospective study in patients undergoing non-cardiac surgery in RSCM from January to December 2015.Considered variable were type of surgery, age, emergency surgery, history of Chronic Obstructive Pulmonary Disease (COPD), serum albumin, ureum, functionalstatus, weight loss, history of smoking, alcohol use, blood transfusions pre surgery, general anaesthesia , history of cerebrovascular disease, acute impaired sensorium, chronic steroid use. Outcomes assessed were complications of respiratory failure and pneumonia 30 days post-operative. Performance calibration were assess with Hosmer-Lemeshow test and performance discrimination were assess with area under the curve ( AUC ) . Result: 403 subjects were meet the inclusion criteria with 74 of subjects had pulmonary complications (18.4 %), 52 subjects had respiratory failure, 34 subjects had pneumonia post operative, and 12 subjects had both complication. Hosmer-Lemeshow test on the complications of respiratory failure showed p = 0.333 and the AUC value is 0.911. While pneumonia complications showed p = 0.617 and AUC value is 0.789. Conclusion: Arozullah score perioperative had good performance in predicting respiratory failure and pneumonia 30-days post operative in RSCM. Key Word: respiratory failure, pneumonia, non cardiac surgery, validation, risk index score perioperative Arozullah;"

"[Integrasi teori model need for help Wiedenbach dengan self care Orem pada asuhan keperawatan pasien dengan mola hidatidosa menjadi kerangka kerja praktik Residensi keperawatan maternitas selama satu tahun. Laporan ini bertujuan untuk memberikan gambaran asuhan keperawatan pada kehamilan normal dan resiko tinggi, perempuan yang mengalami masalah reproduksi, dan ginekologi pada tatanan klinik atau komunitas. Hasil Residensi menunjukan bahwa kedua model tersebut efektif dan efesien dalam membantu mengatasi permasalahan pasien dengan mola hidatidosa. Pencapaian kompetensi Perawat Spesialis Maternitas dilakukan melalui penerapan peran Perawat secara komprehensif., Integration theory models Wiedenbach need for help with self-care Orem on nursing care of patients with hydatidiform mole into the framework of maternity nursing practice residency for one year. This report aims to provide an overview of nursing care in the normal and high-risk pregnancy, women who have reproductive problems, and gynecology at the clinic or community order. Residency results showed that both models are effective and efficient in helping to overcome the problems of patients with hydatidiform mole. Achievement of competence Specialist Nurse Maternity Nurse role is done through the implementation of a comprehensive manner.]"